OpenAlex
PricingAboutJobs
Log inGet started
Work

CLL-1196: Pirtobrutinib Following Covalent BTK Inhibitor Exposure in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Pooled Analysis

HTML

Year: 2026
Type: conference-abstract
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/s2152-2650(26)02089-6
Authors: Rishi Nanda, Daniel Jones, Charles Larson, Ramaditya Srinivasmurthy, Jason Ta, Abbas Ali Hussain, Riccesha Hattin, Akanksha Nanda, Vivek Desai, Kyaw Zin Thein
Institutions: University of Nevada, Las Vegas, Mount Sinai Hospital, University of South Florida, HCA Healthcare, Comprehensive Cancer Centers of Nevada
Language: English

Topic: Chronic Lymphocytic Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory chronic lymphocytic leukemia, covalent BTK inhibitors, treatment sequencing, progression-free survival, time to next treatment, atrial fibrillation, treatment toxicity, overall response rate
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7204696942
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security